RT Book, Section A1 Shinkai, Kanade A1 Fox, Lindy P. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. SR Print(0) ID 1175804635 T1 Reactive Erythemas T2 Current Medical Diagnosis & Treatment 2021 YR 2021 FD 2021 PB McGraw-Hill Education PP New York, NY SN 9781260469868 LK accessmedicine.mhmedical.com/content.aspx?aid=1175804635 RD 2023/02/01 AB Key Clinical Updates in Reactive ErythemasLigelizumab is effective for chronic urticaria in early clinical trials.Etanercept is emerging as a promising therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis and is now the treatment of choice in some centers.